Nova Patents
PL3517541T3

Polymorphic form of fluticasone propionate

Abstract

This record has no abstract on file.

Term

6.6 yearsto projected expiry

Projected expiry 6 May 2033, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

68 members in 19 offices

This recordMember, by publication datePriority claim9 more offices are in the list below

Priority claims33

Priority claims
DocumentOfficeKindDate
201261644105United States of AmericaP
201261644105United States of AmericaP
201261657239United States of AmericaP
201261657239United States of AmericaP
201261692487United States of AmericaP
201261692487United States of AmericaP
201313735973United States of AmericaA
201313735973United States of AmericaA
201361763770United States of AmericaP
201361763770United States of AmericaP
201361788519United States of AmericaP
201361788519United States of AmericaP
13787795European Patent Office (EPO)A
13787795European Patent Office (EPO)A
19156409European Patent Office (EPO)A
2013039694United States of AmericaW
2013039694United States of AmericaW
191564095–––
201261644105P–––
201261657239P–––
201261692487P–––
201313735973–––
201361763770P–––
201361788519P–––
EP20130787795–––
EP20150006409–––
US201261644105P–––
US201261657239P–––
US201261692487P–––
US201313735973–––
US201361763770P–––
US201361788519P–––
WO2013US39694–––

Members68

Family members, oldest first
DocumentOfficeKind
CA2872845A1CanadaA1
US2013303502A1United States of AmericaA1
WO2013169647A1World Intellectual Property Organization (WIPO)A1
US8765725B2United States of AmericaB2
CA2897670A1CanadaA1
WO2014107231A1World Intellectual Property Organization (WIPO)A1
AU2013259872A1AustraliaA1
KR20150013158ARepublic of KoreaA
CN104350063AChinaA
EP2847207A1European Patent Office (EPO)A1
US2015126483A1United States of AmericaA1
IN9326DEN2014AIndiaA
JP2015520149AJapanA
MX2014013523AMexicoA
EP2847207A4European Patent Office (EPO)A4
EP2941437A1European Patent Office (EPO)A1
US2015337006A1United States of AmericaA1
HK1207087AHong Kong, ChinaA
HK1207087A1Hong Kong, ChinaA1
RU2014149115ARussian FederationA
EP2941437A4European Patent Office (EPO)A4
ZA201408119BSouth AfricaB
BR112014027681A2BrazilA2
US9815865B2United States of AmericaB2
US9822142B2United States of AmericaB2
CN104350063BChinaB
US2018022775A1United States of AmericaA1
JP6285419B2JapanB2
CN107880091AChinaA
JP2018083846AJapanA
AU2013259872B2AustraliaB2
RU2663117C2Russian FederationC2
EP2941437B1European Patent Office (EPO)B1
ES2694102T3SpainT3
MX361886BMexicoB
US10174071B2United States of AmericaB2
RU2018125932ARussian FederationA
EP2847207B1European Patent Office (EPO)B1
HK1252481AHong Kong, ChinaA
HK1252481A1Hong Kong, ChinaA1
US2019169224A1United States of AmericaA1
EP3517541A1European Patent Office (EPO)A1
JP6564891B2JapanB2
JP2019167382AJapanA
ES2727474T3SpainT3
KR102129426B1Republic of KoreaB1
EP3517541B1European Patent Office (EPO)B1
PT3517541TPortugalT
DK3517541T3DenmarkT3
JP6752940B2JapanB2
EP3741772A1European Patent Office (EPO)A1
JP2020189877AJapanA
CN107880091BChinaB
PL3517541T3This recordPolandT3
HUE050993T2HungaryT2
ES2813397T3SpainT3
US10954263B2United States of AmericaB2
CA2897670CCanadaC
US2021300963A1United States of AmericaA1
CA2872845CCanadaC
JP6972255B2JapanB2
RU2018125932A3Russian FederationA3
BR112014027681B1BrazilB1
BR112014027681B8BrazilB8
US11814408B2United States of AmericaB2
EP3741772B1European Patent Office (EPO)B1
EP3741772C0European Patent Office (EPO)C0
ES2983481T3SpainT3